The Wall
Martin Mackay, head of Pfizer's research and development, told the newspaper the cuts are part of a continuing effort to focus research work on treatments with the best chances of reaching the market.
The report said major drug makers are finding that in-house research is too costly.
"Nobody in the industry is happy with our productivity," Mackay said.
Source : UPI
[tags : recession bankrupt collapse retrenchment financial news collapse stagnation economic slowdown financial collapse world recession global recession layoff job cut]
0 comments:
Post a Comment